EP0673236A4 - Procede permettant de stimuler la production de la heme oxygenase au moyen de la vitamine b12. - Google Patents

Procede permettant de stimuler la production de la heme oxygenase au moyen de la vitamine b12.

Info

Publication number
EP0673236A4
EP0673236A4 EP94903578A EP94903578A EP0673236A4 EP 0673236 A4 EP0673236 A4 EP 0673236A4 EP 94903578 A EP94903578 A EP 94903578A EP 94903578 A EP94903578 A EP 94903578A EP 0673236 A4 EP0673236 A4 EP 0673236A4
Authority
EP
European Patent Office
Prior art keywords
vitamin
heme oxygenase
stimulating production
stimulating
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP94903578A
Other languages
German (de)
English (en)
Other versions
EP0673236A1 (fr
Inventor
Richard D Levere
Nadar G Abraham
Michal L Schwartzman
Michael W Dunn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hemogen Inc
Original Assignee
Hemogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hemogen Inc filed Critical Hemogen Inc
Publication of EP0673236A1 publication Critical patent/EP0673236A1/fr
Publication of EP0673236A4 publication Critical patent/EP0673236A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20—Halogens; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/001—Preparations for care of the lips
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
EP94903578A 1992-12-10 1993-12-09 Procede permettant de stimuler la production de la heme oxygenase au moyen de la vitamine b12. Withdrawn EP0673236A4 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US77834 1987-07-27
US99079392A 1992-12-10 1992-12-10
US990793 1992-12-10
US7783493A 1993-06-15 1993-06-15
PCT/US1993/012024 WO1994013252A1 (fr) 1992-12-10 1993-12-09 Procede permettant de stimuler la production de la heme oxygenase au moyen de la vitamine b12

Publications (2)

Publication Number Publication Date
EP0673236A1 EP0673236A1 (fr) 1995-09-27
EP0673236A4 true EP0673236A4 (fr) 1999-07-07

Family

ID=26759730

Family Applications (1)

Application Number Title Priority Date Filing Date
EP94903578A Withdrawn EP0673236A4 (fr) 1992-12-10 1993-12-09 Procede permettant de stimuler la production de la heme oxygenase au moyen de la vitamine b12.

Country Status (4)

Country Link
EP (1) EP0673236A4 (fr)
AU (1) AU680222B2 (fr)
CA (1) CA2151148A1 (fr)
WO (1) WO1994013252A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4319629A1 (de) * 1993-06-15 1994-12-22 Karsten Klingelhoeller Verwendung von Corrinoiden zur topischen Anwendung bei Hauterkrankungen
CA2132690A1 (fr) * 1994-09-22 1996-03-23 Dean Willis Controle et modulation de la reponse inflammatoire chez les sujets qui en ont besoin
US6066333A (en) * 1994-09-22 2000-05-23 William Harvey Research Limited Pharmaceutical control of inflammation
AU723677B2 (en) * 1994-09-22 2000-08-31 William Harvey Research Limited Pharmaceutical control of inflammation
AU771728B2 (en) * 1998-12-28 2004-04-01 Ya Global Investments, Lp Cyanocobalamin (vitamin B12) treatment in allergic disease
CA2313659A1 (fr) * 2000-07-06 2002-01-06 Barry J. Barclay Compositions de complexe de la vitamine b qui protegent contre les lesions cellulaires causees par la lumiere ultraviolette
DE10053155A1 (de) * 2000-10-26 2002-05-08 Erika Jungkeit Verwendung eines Multivitaminpräparats zur Behandlung der Schuppenflechte
DE10130846A1 (de) * 2001-06-28 2003-01-16 Regeneratio Pharma Ag Verwendung von Corrinoiden zur Anwendung bei Hauterkrankungen

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3577537A (en) * 1970-03-09 1971-05-04 Merck & Co Inc Topical administration of vitamin b-12
DE2619100A1 (de) * 1976-05-03 1977-11-10 Koehler Valentin Verwendung von glucuronsaeure oder glucuronsaeure-gamma-lacton als hemmstoff fuer beta-glucuronidase
US5102670A (en) * 1990-09-14 1992-04-07 Abraham Nader G Method for treating eye disorders by reducing 12(r)-hydroxyeicosatetraenoic acid and 12(r)-dihydroxyeicosatrienoic acid levels

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4007266A (en) * 1968-05-03 1977-02-08 Choay S.A. Pharmaceutical composition containing vitamin B12, process of making the same and method of treatment
HU195618B (en) * 1981-03-17 1988-06-28 Human Oltoanyagtermelo Process for producing composition for treating epidermic lesions of skin
US4724231A (en) * 1985-04-16 1988-02-09 Nastech Pharmaceutical, Inc. Nasel compositions containing vitamin B12
EP0218679B1 (fr) * 1985-04-16 1991-12-11 Nastech Pharmaceutical Company, Inc. Compositions d'aerosol pour administration par voie nasale de vitamine b 12
US5053222A (en) * 1989-06-07 1991-10-01 Shiseido Company Ltd. Hair cosmetic composition
ATE86111T1 (de) * 1989-08-31 1993-03-15 Takeda Chemical Industries Ltd Vitamin-b12-zusammensetzung.

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3577537A (en) * 1970-03-09 1971-05-04 Merck & Co Inc Topical administration of vitamin b-12
DE2619100A1 (de) * 1976-05-03 1977-11-10 Koehler Valentin Verwendung von glucuronsaeure oder glucuronsaeure-gamma-lacton als hemmstoff fuer beta-glucuronidase
US5102670A (en) * 1990-09-14 1992-04-07 Abraham Nader G Method for treating eye disorders by reducing 12(r)-hydroxyeicosatetraenoic acid and 12(r)-dihydroxyeicosatrienoic acid levels

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
"Vitamine B12 Lavoisier 5,000 microgrammes", DICTIONNAIRE VIDAL, 1992, XP002086458 *
See also references of WO9413252A1 *

Also Published As

Publication number Publication date
AU5747294A (en) 1994-07-04
WO1994013252A1 (fr) 1994-06-23
EP0673236A1 (fr) 1995-09-27
CA2151148A1 (fr) 1994-06-23
AU680222B2 (en) 1997-07-24

Similar Documents

Publication Publication Date Title
AU5085593A (en) Method for making vitamin enriched cereal
HU9301715D0 (en) Method for producing new sulfamate-imidate derivatives
HU9202172D0 (en) New n-benzoyl-amino-acid derivatives, medical preparatives containing said compounds and method for producing them
EP0661124A3 (fr) Méthode pour l'usinage des matériaux composites.
HU9301070D0 (en) Method for producing biphenyl derivatives
AU567613B2 (en) Method for treatment of neoplasms.
HUT72660A (en) Intermediates for producing benzopirane derivatives, and process for producing them
EP0602922A3 (fr) Procédé pour la préparation des silanes substitués par le groupement dicyloalkyle.
HU9202020D0 (en) Microbiological method for producing mevinoline
EP0673236A4 (fr) Procede permettant de stimuler la production de la heme oxygenase au moyen de la vitamine b12.
HU9300657D0 (en) Method for producing dialkyl-2,3-pyridine-dicarboxylate derivatives
HUT71257A (en) Process for producing vitamin e
EP0579095A3 (fr) Produits alimentaires pour animaux et leur méthode de production.
DE3462601D1 (en) Process for the production of compounds of the vitamin k series and of ubichinones, and intermediate compounds
DE3372214D1 (en) Process for producing vitamin b12 by the fermentation technique, and vitamin b12-producing microorganism
HU9300999D0 (en) Method for producing imidazo-pyridines
EP0571352A3 (fr) Méthode pour l'usinage de matériaux composites.
HU9203135D0 (en) New 17-beta-substituted 4-aza-androstane derivatives and method for producing them
HUP9904603A3 (en) Vitamin d3 derivatives, medicaments containing the same and process for production thereof
HU9302277D0 (en) Method for producing imidazo-pyridine derivatives
EP0794175A3 (fr) Procédé de préparation des dérivés de vitamine D3
HU9300117D0 (en) Method for producing 1,4-benzo-diazepine derivatives
EP0563825A3 (en) Process for producing vitamin a acid
EP0586819A3 (fr) Procédé pour la fabrication de diméthylnaphtalène.
HU9300183D0 (en) Method for producing 4,6-dialkoxi-pyrimidine derivatives

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19950609

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 19990519

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19990701